The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 24, 2018

Filed:

Jan. 17, 2013
Applicants:

Xiamen University, Xiamen, CN;

Xiamen Innovax Biotech Co., Ltd., Xiamen, CN;

Inventors:

Quan Yuan, Xiamen, CN;

Liuwei Song, Xiamen, CN;

Wenbin Zhou, Xiamen, CN;

Zuxing Weng, Xiamen, CN;

Feihai Xu, Xiamen, CN;

Shengxiang Ge, Xiamen, CN;

Jun Zhang, Xiamen, CN;

Ningshao Xia, Xiamen, CN;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/576 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56983 (2013.01); G01N 33/5762 (2013.01); G01N 2333/02 (2013.01); G01N 2469/20 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01);
Abstract

The present invention relates to a method for quantitative detection of anti-HBc and its use in monitoring disease progression of chronic hepatitis B patients and predicting therapeutic effects. By quantitative detection of antibodies against hepatitis B core protein (Anti-HBc), it is able to monitor disease progression of chronic hepatitis B patients, effectively predict therapeutic effects in chronic hepatitis B patients who accept a therapy against hepatitis B virus (especially, a therapy based on interferon and a therapy based on nucleoside/nucleotide analog anti-HBV drug), and thus guide the patients to reasonably choose drugs.


Find Patent Forward Citations

Loading…